VERTEX PHARMACEUTICALS INC
VRTX·92532F100·US·Common Stock·Healthcare - Biotechnology-13D/G
VRTX (VERTEX PHARMACEUTICALS INC) is held by 347 institutional investors as of Q1 2026. Largest holders: Capital World Investors ($11.3B), BlackRock, Inc. ($10.7B), Capital Research Global Investors ($9.4B). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 183 funds bought VRTX.
347
Holders
(31 Elite)
$98.1B
Total Value
52% (354)
Consensus
183 buying - 171 selling
13F: Insider & Congress:
Who's Trading
InsiderBCBozic CarmenSell $614KMay 15, 2026
InsiderBCBozic CarmenSell $3.1MMay 12, 2026
InsiderBNBhatia Sangeeta N.Sell $135KMay 4, 2026
InsiderLJLiu JoySell $469KMay 1, 2026
Showing 1-20 of 359
1 / 18
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer